Skip to main content

Oncolytics Biotech Inc

ONCY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001129928

No open-market purchases or sales by Oncolytics Biotech Inc insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $3.76M in total; no superinvestor holds it.

Superinvestors holding ONCY, Q2 2026

See all superinvestors

No superinvestor reported holding ONCY in Q2 2026.